⌘K
Injecto Polymers operates in the plastic and polymers industry, manufacturing and supplying polymer-based products. The company is undertaking an SME IPO to fund capital expenditure for expansion and repay existing debt.
The company demonstrates impressive historical financial growth and attractive valuation multiples. However, these strengths are significantly undermined by critical financial weaknesses such as negative operating cash flows and a high debt-to-equity ratio. Furthermore, substantial governance red flags, including ongoing litigations and a history of regulatory non-compliance, raise serious concerns. The extremely weak market sentiment, evidenced by very low subscription rates across all investor categories and the absence of a grey market premium, indicates a lack of investor confidence. While the growth trajectory is compelling, the confluence of high financial, governance, and operational risks, coupled with poor market reception, makes this IPO a high-risk proposition.
Absence of GMP and very weak subscription across all categories indicate low investor interest, making significant listing gains unlikely.
While growth is strong, the high financial and governance risks, coupled with weak market sentiment, suggest limited upside in the short term. Volatility is expected.
The company's strong growth trajectory and expansion plans offer long-term potential. However, persistent negative operating cash flows, high debt, and significant governance issues pose substantial risks to long-term sustainability and value creation.
| Category | Shares Offered | % of Issue | Share |
|---|---|---|---|
| QIB | 15,96,000 | 28.44% | |
| NII (HNI) | 18,66,000 | 33.25% | |
| Retail | 18,67,200 | 33.27% | |
| Market Maker | 2,83,200 | 5.05% |
| Investor | |||
|---|---|---|---|
| LONGTHRIVE CAPITAL VCC-TRENDVIEW CAPITAL FUND | 3,99,600 | ₹4 Cr | 41.73% |
| CRAFT EMERGING MARKET FUND PCC-CITADEL CAPITAL FUND | 3,00,000 | ₹3 Cr | 31.33% |
| CRAFT EMERGING MARKET FUND PCC-ELITE CAPITAL FUND | 2,58,000 | ₹2.58 Cr | 26.94% |
Grey-market premium history is not yet available for this issue.
Exceptional historical revenue and PAT growth (CAGR ~90%).
Strong return ratios (ROE 28.94%, ROCE 15.64%, RoNW 41.73%).
Reasonable post-IPO valuation (P/E 12.99x, P/B 2.4x) relative to growth.
Healthy promoter holding post-IPO (64.35%).
Presence of three institutional anchor investors.
Clear capital expenditure plans for manufacturing facility expansion.
Successful execution of Phase IV expansion, diversification of customer and supplier base, improved operating cash flows, favorable industry growth, and resolution of legal/regulatory issues.
Steady execution of expansion plans, stable raw material prices, continued demand for polymer products, and gradual improvement in financial management.
Delays in expansion, increased competition, adverse regulatory actions, sustained negative cash flows, inability to manage high debt, and unfavorable economic conditions.
Positive: Exceptional historical revenue and PAT growth (CAGR ~90%).
Red flag: high leverage (D/E 2.61) -> -7.8 pts on fundamentals
Advisory: litigation disclosed (advisory, not a specific severe matter)
Listing-gain vs long-term: Avoid / Avoid.